Previous 10 | Next 10 |
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a novel bioelectric medicine company, today announced preliminary results of its rights offering, which expired at 5:00 p.m. Eastern Time on June 8, 2020 (the “Expiration Date...
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a novel bioelectric medicine company, today announced that it has commenced its previously-announced rights offering of up to 4,279,600 of units (the “Units,” and each, a &...
Image source: The Motley Fool. Pulse Biosciences, Inc Common Stock (NASDAQ: PLSE) Q1 2020 Earnings Call May 11, 2020 , 4:30 p.m. ET Operator Continue reading
Pulse Biosciences, Inc. (PLSE) Q1 2020 Earnings Conference Call May 11, 2020, 04:30 PM ET Company Participants Philip Taylor - Investor Relations Darrin Uecker - President and Chief Executive Officer Ed Ebbers - Executive Vice President and General Manager, Dermatology Sandy Ga...
Pulse Biosciences (NASDAQ: PLSE ): Q1 GAAP EPS of -$0.57. More news on: Pulse Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company, today announced financial results for the first quarter ended March 31, 2020. Recent Highlights Completed Pre-Submission meeting with the U.S. Food and Drug Administration (FDA) to establish the criteria...
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a novel bioelectric medicine company, today announced that it has updated the structure, key dates and pricing terms for its previously-announced rights offering. The Company intends...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company, announced today it will report financial results for the first quarter 2020 after market close on Monday, May 11, 2020. Company management will host a corresponding conference call beginning at 1:30pm PT. Invest...
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company”, or “Pulse Biosciences”) today announced that it filed a registration statement on Form S-3 with the Securities and Exchange Commission (the “SEC”) for a rights offering to its existing...
Image source: The Motley Fool. Pulse Biosciences, Inc Common Stock (NASDAQ: PLSE) Q4 2019 Earnings Call Mar 16, 2020 , 4:30 p.m. ET Operator Continue reading
News, Short Squeeze, Breakout and More Instantly...
Pulse Biosciences Inc Company Name:
PLSE Stock Symbol:
NASDAQ Market:
Pulse Biosciences Inc Website:
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced it will report financial results for the second quarter 2024 after market close on Monday, August 12, 2024. Company managemen...
2024-07-15 17:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 12.5% to $0.27 on volume of 477,193,667 shares NVIDIA Corporation (NVDA) rose 1.9% to $128.2 on volume of 232,119,115 shares Virpax Pharmaceuticals Inc. (VRPX) rose 92.0% to $1.11 on volume o...